Acceptability of Less Harmful Alternatives to Cigarettes

NCT00957424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2017-02-07

Study results available
· View outcomes & findings →

Summary

RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking.

PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.

Conditions

Interventions

BEHAVIORAL

telephone-based intervention

10-15 minute web-based survey on a computer

DRUG

nicotine replacement therapy

One week supply

OTHER

informational intervention

OTHER

internet-based intervention

OTHER

questionnaire administration

Given out week 2, 3 and 4.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Martin Mahoney, MD · Roswell Park Cancer Institute

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-08-31
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00957424 on ClinicalTrials.gov